Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
The Lancet. Infectious Diseases|July 7, 2023
Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adultsNicole Bézay, Romana Hochreiter, Vera Kadlecek, et al.
Vaccine|January 25, 2021
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trialCassandra Aldrich, Isabel Leroux-Roels, Katell Bidet Huang, et al.
The Journal of Infectious Diseases|March 9, 2026
Induction of a Th1-Type Polyfunctional T Cell Response by the four-segmented Rift Valley Fever candidate vaccine in humansAmare Aregay, Julia Friese, Sharon Porrez, et al.
The New England Journal of Medicine|May 6, 2026
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in AdultsIsabel Leroux-Roels, Grace Huang, Murdo Ferguson, et al.
Vaccine|November 2, 2013
Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trialsIsabel Leroux-Roels, Jeanne-Marie Devaster, Geert Leroux-Roels, et al.
Vaccine|August 24, 2010
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant SystemsIsabel Leroux-Roels, Marguerite Koutsoukos, Frédéric Clement, et al.
The Lancet. Infectious Diseases|July 30, 2023
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trialIsabel Leroux-Roels, Paul Willems, Gwenn Waerlop, et al.
Vaccine|October 20, 2009
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary studyIsabel Leroux-Roels, François Roman, Sheron Forgus, et al.
Clinical and Vaccine Immunology : CVI|September 24, 2010
Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adultsIsabel Leroux-Roels, Geert Leroux-Roels, Opokua Ofori-Anyinam, et al.
Plos One|November 5, 2016
Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly AdultsRajeka Lazarus, Sarah Kelly, Matthew D Snape, et al.
Pageof 8